Chilmark Research April 1, 2020
The COVID-19 crisis is an acid test for the value of telehealth and remote medicine in patient-centered and community care. Our 2018 Telehealth report described the opportunities and regulatory environment telehealth contended in. Now, new exceptions and regulations by CMS, the Office for Civil Rights, and the FDA are easing access, deployment, and promoting the use of telehealth and remote care in the hopes of reducing strain on an over-taxed healthcare system. While these changes are being forced due to an episodic event, COVID-19, there is a strong likelihood that the changes will become systemic, forever changing how care is delivered.
Key takeaways
- Changes in federal and state regulations surrounding telehealth and remote care are expanding access to care...